1. ScholarBank@NUS

Go Mei Lin

rp05949

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Go Mei Lin
Variants
Mei, L.
Mei Lin, G.
Go M.-L.
Go, M.-L.
Go, M.I.
Go, M.L.
Mei, L.G.
Go, Mei Lin
Mei Lin Go
Go, M.
 
Main Affiliation
 
Faculty
 
Email
phagoml@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 3000]
Policy:  Open

Results 1-15 of 15 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
12017A New Generation of Arachidonic Acid Analogues as Potential Neurological Agent Targeting Cytosolic Phospholipase A2Ng C.Y. ; Kannan S.; Chen Y.J. ; Tan F.C.K. ; Ong W.Y.; Go M.L. ; Verma C.S.; Low C.-M. ; Lam Y. 
22017Action of YM155 on clear cell renal cell carcinoma does not depend on surviving expression levelsSim M.Y.; Huynh H. ; Go M.L. ; Yuen J.S.P. 
313-Oct-2022Alkyltriphenylphosphonium turns naphthoquinoneimidazoles into potent membrane depolarizers against mycobacteriaFridianto, KT; Gunawan, GA ; Hards, K; Sarathy, JP; Cook, GM; Dick, T ; Go, ML ; Lam, Y 
413-Apr-2017Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure-Activity Relationships and Membrane Targeting PropertiesYang, Tianming ; Moreira, Wilfried ; Nyantakyi, Samuel Agyei; Chen, Huan; Aziz, Dinah Binte ; Go, Mei-Lin ; Dick, Thomas 
52018Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-?B pathwaySim M.Y.; Yuen J.S.P. ; Go M.L. 
62018Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomasRamayanti, O; Brinkkemper, M; Verkuijlen, S.A.W.M; Ritmaleni, L; Go, M.L ; Middeldorp, J.M
72015Determining the functions of HIV-1 Tat and a second magnesium ion in the CDK9/cyclin T1 complex: A molecular dynamics simulation studyJin, Haixiao; Go, Mei Lin ; Yin, Peng; Qiu, Xiaoting; Zhu, Peng; Yan, Xiaojun
88-Sep-2020Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic ComplicationsOng, Wei-Yi ; Go, Mei-Lin ; Wang, De-Yun ; Cheah, Irwin Kee-Mun ; Halliwell, Barry 
92020Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”Yam, Y.-K.; Alvarez, N.; Go, M.-L. ; Dick, T.
1011-Nov-2021Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosisFridianto, Kevin T; Li, Ming ; Hards, Kiel; Negatu, Dereje A; Cook, Gregory M; Dick, Thomas ; Lam, Yulin ; Go, Mei-Lin 
112019Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosisNegatu, D.A.; Yamada, Y. ; Xi, Y.; Go, M.L. ; Zimmerman, M.; Ganapathy, U.; Dartois, V.; Gengenbacher, M.; Dick, T.
1215-May-2020Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition.Li, Ming; Phua, Zheng Yen; Xi, Yu; Xu, Zhujun ; Nyantakyi, Samuel Agyei; Li, Wei; Jackson, Mary C; Wong, Ming Wah ; Lam, Yulin ; Chng, Shu-Sin ; Go, Mei-Lin ; Dick, Thomas 
1322-Feb-2023PROTAC Antibiotics: The Time is NowJickky Palmae Sarathy ; Courtney C Aldrich; Mei-Lin Go ; Thomas Dick 
142020Rifabutin suppresses inducible clarithromycin resistance in mycobacterium abscessus by blocking induction of whiB7 and erm41Aziz, D.B.; Go, M.L. ; Dick, T.
152018The mycobacterial membrane: A novel target space for anti-tubercular drugsChen H. ; Nyantakyi S.A.; Li M.; Gopal P. ; Aziz D.B. ; Yang T. ; Moreira W. ; Gengenbacher M. ; Dick T. ; Go M.L.